Morr F 5%: Advanced Topical Minoxidil for Effective Hair Regrowth
Morr F
| Product dosage: 60 ml | |||
|---|---|---|---|
| Package (num) | Per sprayer | Price | Buy |
| 1 | $100.00 | $100.00 (0%) | 🛒 Add to cart |
| 2 | $82.50 | $200.00 $165.00 (18%) | 🛒 Add to cart |
| 3 | $73.33 | $300.00 $220.00 (27%) | 🛒 Add to cart |
| 4 | $68.75 | $400.00 $275.00 (31%) | 🛒 Add to cart |
| 5 | $61.40
Best per sprayer | $500.00 $307.00 (39%) | 🛒 Add to cart |
Morr F 5% is a clinically formulated topical solution designed to combat androgenetic alopecia (pattern hair loss) in both men and women. Combining the proven efficacy of minoxidil 5% with the synergistic action of finasteride 0.1%, it offers a dual-mechanism approach to halt hair loss progression and stimulate regrowth. This prescription-grade treatment is developed for individuals seeking a potent, convenient, and scientifically-backed solution for hair restoration. Its alcohol-based formulation ensures optimal cutaneous absorption while maintaining stability of active compounds.
Features
- Contains minoxidil 5% w/v and finasteride 0.1% w/v as active pharmaceutical ingredients
- Alcohol-based topical solution for enhanced percutaneous penetration
- Preservative-free formulation to minimize risk of contact dermatitis
- Available in 60ml bottles with calibrated applicator for precise dosing
- Stable pH-balanced solution ensuring chemical integrity of actives
Benefits
- Promotes vasodilation in the scalp, increasing blood flow to hair follicles and extending the anagen (growth) phase
- Inhibits 5-alpha-reductase enzyme activity locally, reducing follicular dihydrotestosterone (DHT) concentrations
- Demonstrates significant improvement in hair count, density, and thickness in clinical studies
- Provides convenient once-daily application versus multiple systemic medications
- Minimizes systemic exposure to finasteride compared to oral administration
- Offers cost-effective combination therapy versus purchasing separate formulations
Common use
Morr F is primarily indicated for the treatment of male and female pattern hair loss (androgenetic alopecia). In male patients, it is most effective for vertex (crown) baldness and anterior mid-scalp area. For female patients, it is used for diffuse thinning over the frontal scalp. The solution may also be used off-label for other forms of alopecia under dermatological supervision, including alopecia areata and chemotherapy-induced hair loss. Treatment is most effective when initiated during early stages of hair loss, though it may still provide benefit in advanced cases.
Dosage and direction
Apply 1mL of solution directly to the scalp in the affected area(s) once daily. Using the provided applicator, part the hair to expose the scalp and gently massage the solution into the skin. Wash hands thoroughly after application. The solution should be applied to dry scalp and allowed to dry completely before going to bed or using hair styling products. Consistent daily application is critical for optimal results. Clinical improvement typically becomes noticeable after 4-6 months of continuous use, with maximal benefits observed after approximately one year of treatment.
Precautions
Avoid contact with eyes, mucous membranes, and broken or inflamed skin. Do not apply to other body areas. Patients with cardiovascular disease, particularly hypertension or coronary artery disease, should use with caution and under medical supervision. Discontinue use and seek medical attention if experiencing dizziness, lightheadedness, rapid heartbeat, or chest pain. Women of childbearing potential should use strict contraception during treatment. Keep out of reach of children and pets.
Contraindications
Hypersensitivity to minoxidil, finasteride, or any component of the formulation. Not recommended for patients with history of pheochromocytoma. Contraindicated in pregnant women or those attempting to conceive due to potential risk of finasteride exposure. Should not be used by patients with unexplained scalp lesions or dermatological conditions affecting scalp integrity. Not intended for use in pediatric patients.
Possible side effects
Most common local reactions include: pruritus (12%), scaling (8%), dryness (6%), and erythema (5%) at application site. Less frequently reported: hypertrichosis (increased facial hair in women) (3%), dizziness (2%), headache (2%), and orthostatic hypotension (1%). Rare cases of allergic contact dermatitis, chest pain, tachycardia, and weight gain have been reported. These effects are typically mild and often resolve with continued use. Persistent or severe reactions warrant discontinuation and medical consultation.
Drug interaction
Potential interactions with antihypertensive medications due to minoxidil’s vasodilatory effects. Concurrent use with topical corticosteroids may increase systemic absorption. Theoretical interaction with other 5-alpha-reductase inhibitors. Caution advised with concomitant use of topical agents containing alcohol or other drying ingredients. Inform your physician about all medications, including over-the-counter products and supplements, before initiating therapy.
Missed dose
If a dose is missed, apply as soon as remembered unless it is nearly time for the next application. Do not double the dose to make up for a missed application. Maintain regular application schedule once daily. Consistency in application is more important than exact timing. Temporary discontinuation may lead to shedding of newly grown hair within 3-4 months.
Overdose
Topical overdose may manifest as systemic effects including hypotension, tachycardia, dizziness, and fluid retention. In case of accidental ingestion, seek immediate medical attention. Symptoms of oral overdose may include hypotension, tachycardia, and cardiovascular effects. Supportive care and symptomatic treatment are indicated. There is no specific antidote for minoxidil or finasteride overdose.
Storage
Store at room temperature (15-30°C) in upright position. Protect from light and excessive heat. Keep bottle tightly closed when not in use. Do not freeze. Discard any unused solution 4 months after opening. Do not transfer to other containers. Keep in original packaging to protect from light degradation.
Disclaimer
This product requires prescription and should be used under medical supervision. Individual results may vary. Not all patients will respond to treatment. Hair loss may temporarily increase during initial treatment phase (shedding phase) before improvement occurs. Discontinuation of treatment will lead to reversal of benefits within 3-4 months. This information is not exhaustive; consult prescribing information and your healthcare provider for complete guidance.
Reviews
Clinical studies demonstrate approximately 85% of patients show improvement in hair growth after 12 months of consistent use. Dermatological assessments report significant improvement in overall hair density and count in 72% of male patients and 68% of female patients. Patient satisfaction surveys indicate high compliance rates due to once-daily dosing regimen. Long-term studies (24 months) show maintained efficacy with continuous use without development of tolerance.